Microbiome Sequencing Services Market Share, Size, Trends, Industry Analysis Report, By Technology (Sequencing by Synthesis, Sequencing by Ligation, Sanger Sequencing); By Application; By End-user; By Region, And Segment Forecasts, 2023 - 2032

Microbiome Sequencing Services Market Share, Size, Trends, Industry Analysis Report, By Technology (Sequencing by Synthesis, Sequencing by Ligation, Sanger Sequencing); By Application; By End-user; By Region, And Segment Forecasts, 2023 - 2032

The global microbiome sequencing services market size is expected to reach USD 1,032.39 million by 2032, according to a new study by Polaris Market Research. The report “Microbiome Sequencing Services Market Share, Size, Trends, Industry Analysis Report, By Technology (Sequencing By Synthesis, Sequencing By Ligation, Sanger Sequencing), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The significant impact of microbiomes on human health has driven substantial progress in microbiome sequencing research over the past few years. With advances in sequencing technologies and substantial reductions in the costs of these services, it has become easier to conduct studies on the diversity of microbes present in and on the human body. The potential for developing novel treatments and preventative measures for various diseases, including cancer, auto-immune conditions, & infectious diseases, has driven research on the human body's microbiome impacts human physiology. The growing research in this field is likely to drive demand for microbiome sequencing services as scientists and researchers continue to explore the relationship between the microbiome and human health.

The COVID-19 pandemic has indeed had a positive impact on the market for microbiome sequencing services. The pandemic led to an increased adoption of microbiome sequencing tools, especially in the fields of infectious diseases and cancer research. RNA sequencing, which is one of the applications of microbiome sequencing, was utilized to determine the presence of the virus and the host's response to COVID-19. This increased demand for microbiome sequencing services and tools during the pandemic is expected to continue to drive market growth in the coming years.

Government funding for research on COVID-19 and partnerships with industry participants have also played a significant role in fueling the demand for the services during the pandemic. The microbiome sequencing services market is also being fueled by rising investment & advancements in the genomic research. As more companies and research institutions invest in microbiome sequencing technologies, the market is expected to see significant growth in the coming years. Additionally, the increasing number of collaborations and partnerships among key players in the market is also expected to contribute to market growth.

Microbiome Sequencing Services Market Report Highlights

Sequence by synthesis segment held the largest share, owing to its ability to run parallel pairs of sequences within stipulated time and cost

Gastro-intestinal segment held largest revenue, primarily due to rise in cases of bowel diseases and damages in the gut micro-biota due to changing life-style

Research institutes garnered substantial share, owing to rise funding for microbiome research and nationwide programs on micro-biome analysis

North America is held the largest share, due presence of innovative companies, decline in sequencing costs, and significant investments

The global players include Microbiome Insights, Baseclear, Clinical-Microbiomics, Mérieux NutriSciences Corp., MR DNA, Metabiomics Corp., Rancho BioSciences, Second Genome, Zymo Research Corporation, and uBiome.

Polaris Market Research has segmented the microbiome sequencing services market report based on technology, application, end use, and region:

Microbiome Sequencing Services, Technology Outlook (Revenue - USD Million, 2019 - 2032)

Sequencing by synthesis

Sequencing by ligation

Sanger sequencing

Others

Microbiome Sequencing Services, Application Outlook (Revenue - USD Million, 2019 - 2032)

Autoimmune Disorder

Cancer

Gastrointestinal Disorders

Others

Microbiome Sequencing Services, End Use Outlook (Revenue - USD Million, 2019 - 2032)

Pharmaceutical & biotechnology companies

Academic research institutes

Others

Microbiome Sequencing Services, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa